SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-271098
Filing Date
2020-10-16
Accepted
2020-10-16 16:12:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d23230d424b5.htm 424B5 369781
2 GRAPHIC g23230g68w42.jpg GRAPHIC 65640
3 GRAPHIC g23230g93w91.jpg GRAPHIC 65640
  Complete submission text file 0001193125-20-271098.txt   552019
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-242372 | Film No.: 201244118
SIC: 2836 Biological Products, (No Diagnostic Substances)